Short Interest in PharmaCielo Ltd. (OTCMKTS:PCLOF) Increases By 25.0%

PharmaCielo Ltd. (OTCMKTS:PCLOF) was the recipient of a significant increase in short interest in the month of March. As of March 13th, there was short interest totaling 70,220 shares, an increase of 25.0% from the February 26th total of 56,169 shares. Based on an average trading volume of 117,284 shares, the short-interest ratio is presently 0.6 days.

PharmaCielo Price Performance

Shares of PCLOF opened at $0.04 on Monday. The business’s 50 day moving average is $0.05 and its 200 day moving average is $0.04. PharmaCielo has a 12-month low of $0.00 and a 12-month high of $0.12.

PharmaCielo Company Profile

PharmaCielo (OTCMKTS:PCLOF) is a Colombia-based, vertically integrated cannabinoid extraction and manufacturing company that develops pharmaceutical-grade active ingredients for the global medical cannabis market. The company specializes in the cultivation, extraction, purification and isolation of cannabinoids, producing a range of high-purity oils, distillates and isolates that serve as the active pharmaceutical ingredients (APIs) in end-use formulations. PharmaCielo’s product portfolio is designed to meet Good Manufacturing Practices (GMP) standards, enabling partnerships with pharmaceutical firms and wellness brands seeking compliant, consistently standardized cannabinoid inputs.

Since commencing operations, PharmaCielo has established a state-of-the-art extraction facility in Colombia, leveraging the country’s favorable agronomic conditions and regulatory framework for medicinal cannabis cultivation.